Start for free
Start for free
OL

Orient Life

Description

Orient Life

Investor Profile

Orient Life has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Therapeutics
  • Clinical Trials
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Orient Life frequently co-invest with?

GH
Global health sciences venture fund
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
EM
Everblue Management
North America, New York, United States, New York
Co-Investments: 1
JDRF T1D Fund
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
Polaris Partners
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Illumina Ventures
Illumina Ventures
North America, California, United States, Foster City
Co-Investments: 1
BH
BRIDGE Healthcare Partners
North America, Colorado, United States, Denver
Co-Investments: 1
+ND Capital
+ND Capital
North America, California, United States, San Mateo
Co-Investments: 1
Alumni Ventures
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1
Invus
Invus
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by Orient Life?

Lyndra Therapeutics

Watertown, Massachusetts, United States

Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.

BiotechnologyClinical TrialsHealth CarePharmaceutical
Series BFeb 11, 2019
Amount Raised: $60,900,000
SQZ Biotech

Watertown, Massachusetts, United States

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

BiotechnologyLife ScienceTherapeutics
Series CAug 8, 2018
Amount Raised: $72,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator